Virtus Lifesci Biotech Etf Equity Positions Weight
| BBP Etf | USD 52.38 0.72 1.36% |
Virtus LifeSci Biotech fundamentals help investors to digest information that contributes to Virtus LifeSci's financial success or failures. It also enables traders to predict the movement of Virtus Etf. The fundamental analysis module provides a way to measure Virtus LifeSci's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virtus LifeSci etf.
Virtus |
Virtus LifeSci Biotech ETF Equity Positions Weight Analysis
Virtus LifeSci's Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Current Virtus LifeSci Equity Positions Weight | 98.73 % |
Most of Virtus LifeSci's fundamental indicators, such as Equity Positions Weight, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virtus LifeSci Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
| Competition |
Virtus LifeSci Equity Positions Weight Component Assessment
According to the company disclosure, Virtus LifeSci Biotech has an Equity Positions Weight of 98%. This indicator is about the same for the Virtus average (which is currently at 97.94) family and about the same as Health (which currently averages 97.94) category. The equity positions weight for all United States etfs is 86.92% lower than that of the firm.
Virtus Equity Positions Weight Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virtus LifeSci's direct or indirect competition against its Equity Positions Weight to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Virtus LifeSci could also be used in its relative valuation, which is a method of valuing Virtus LifeSci by comparing valuation metrics of similar companies.Virtus LifeSci is currently under evaluation in equity positions weight as compared to similar ETFs.
Fund Asset Allocation for Virtus LifeSci
The fund consists of 98.73% investments in stocks, with the rest of investments allocated between various types of exotic instruments.Asset allocation divides Virtus LifeSci's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Virtus Fundamentals
| Price To Earning | 18.03 X | |||
| Price To Book | 1.66 X | |||
| Price To Sales | 5.60 X | |||
| Number Of Employees | 12 | |||
| Beta | 0.65 | |||
| Total Asset | 15.87 M | |||
| One Year Return | 7.40 % | |||
| Three Year Return | 1.50 % | |||
| Five Year Return | 3.80 % | |||
| Net Asset | 15.87 M | |||
| Equity Positions Weight | 98.73 % |
About Virtus LifeSci Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virtus LifeSci Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virtus LifeSci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virtus LifeSci Biotech based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Virtus LifeSci
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Virtus LifeSci position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus LifeSci will appreciate offsetting losses from the drop in the long position's value.Moving together with Virtus Etf
| 0.68 | IBB | iShares Biotechnology ETF | PairCorr |
Moving against Virtus Etf
| 0.6 | BTR | Northern Lights | PairCorr |
| 0.57 | PULS | PGIM Ultra Short Sell-off Trend | PairCorr |
| 0.52 | SPAQ | Horizon Kinetics SPAC | PairCorr |
The ability to find closely correlated positions to Virtus LifeSci could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Virtus LifeSci when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Virtus LifeSci - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Virtus LifeSci Biotech to buy it.
The correlation of Virtus LifeSci is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Virtus LifeSci moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Virtus LifeSci Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Virtus LifeSci can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Virtus LifeSci Piotroski F Score and Virtus LifeSci Altman Z Score analysis. Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.